• LAST PRICE
    70.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    51.0000/ 1
  • Ask / Lots
    700.0000/ 1
  • Open / Previous Close
    0.0000 / 70.0000
  • Day Range
    ---
  • 52 Week Range
    Low 59.0000
    High 104.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 70
TimeVolumeBIOQ
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBIOQ
Bioqual Inc
62.6M
-136.8x
-25.28%
United StatesCDTX
Cidara Therapeutics Inc
65.0M
-1.9x
---
United StatesATRA
Atara Biotherapeutics Inc
72.5M
-0.3x
---
United StatesPSNL
Personalis Inc
73.5M
-0.6x
---
United StatesSRNEQ
Sorrento Therapeutics Inc
15.4M
0.0x
---
United StatesRDHL
Redhill Biopharma Ltd
15.7M
-0.1x
---
As of 2024-02-27

Company Information

Bioqual, Inc. is engaged in performing contract research services, which is focused on in vivo models of human diseases, including COVID-19, acquired immune deficiency syndrome (AIDS), influenza, Mpox, respiratory syncytial virus (RSV) infection, Flavivirus infections, including zika and dengue, malaria, hepatitis, and cancer. It is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. The Company also performs in vitro contract research services. The in vitro services include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation and other cell-based assays. It also provides research services in herpes simplex in rodents, filariasis in rhesus macaques, chikungunya in rodents and macaques and dengue in rodents and macaques.

Contact Information

Headquarters
9600 Medical Center Drive, Suite 101ROCKVILLE, MD, United States 20850-3336
Phone
240-404-7654
Fax
240-404-7664

Executives

Chairman of the Board, President, Chief Executive Officer
Mark Lewis
Chief Financial Officer
Charles Kirk
Chief Scientific Officer
Hanne Elyard
Vice President - Operations
MITCH FRANKLIN
Vice President - Facility Operations, Director - Information Technology
Chander Sarma

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$62.6M
Revenue (TTM)
$61.6M
Shares Outstanding
894.4K
Dividend Yield
0.71%
Annual Dividend Rate
0.5000 USD
Ex-Dividend Date
10-05-23
Pay Date
10-27-23
Beta
-0.37
EPS
$-0.51
Book Value
$42.05
P/E Ratio
-136.8x
Price/Sales (TTM)
1.0
Price/Cash Flow (TTM)
30.2x
Operating Margin
-1.54%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.